The FY22 Defense Appropriations Act is anticipated to provide funding for the Lung Cancer Research Program to support high-impact lung cancer research.
Although FY22 funds have not yet been appropriated for the LCRP, the Congressionally Directed Medical Research Programs issued a pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY22 funding opportunities. This pre-announcement should not be construed as an obligation by the government.
The FY22 LCRP funding opportunity announcements for the included award mechanisms will be posted on the Grants.gov website. Pre-application and application deadlines will be available when the announcements are released.
Applications submitted to the FY22 LCRP must address one or more of the following areas of emphasis:
- Identify innovative strategies for the prevention of the occurrence of lung cancer
- Identify innovative strategies for the screening and early detection of lung cancer
- Understand the molecular mechanisms of initiation and progression to lung cancer
- Understand contributors to lung cancer development other than tobacco
- Identify innovative strategies for the treatment of lung cancer
- Identify innovative strategies for the prevention of recurrence of or metastases from lung cancer
- Develop or optimize biomarkers to assist with therapeutic decision-making
- Understand mechanisms of resistance to treatment (primary and secondary)
- Identify innovative strategies for comprehensive lung cancer care (clinical management/surveillance/symptom management/palliative care)
- Understand factors and/or develop implementation strategies to address health disparities in lung cancer
The LCRP seeks to support research that is relevant to the healthcare needs of military service members, veterans, and their families. Relevance to military health will be considered in determining relevance to the mission of the DHP and FY22 LCRP during programmatic review. Investigators are strongly encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health:
- Use of military or veteran populations, biospecimens, data/databases, or programs in the proposed research
- Collaboration with Department of Defense or Department of Veterans Affairs investigators
- Description of how the knowledge, information, products, or technologies gained from the proposed research could be implemented in a dual-use capacity to address a military need that also benefits the civilian population
- Explanation of how the project addresses an aspect of lung cancer that has a direct relevance to military service members, veterans, or other military health system beneficiaries, including environmental exposures other than tobacco
There are several award mechanisms under the LCRP, including: Concept Award, Career Development Award, Idea Development Award, Investigator-Initiated Translational Research Award, and Clinical Translational Research Partnership Award. Details about eligibility, relevant research areas, and funding for these award mechanisms are available here.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) here prior to the pre-application deadline.
All applications must conform to the final funding opportunity announcements that will be available for downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov.
A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA number 12.420.
